Cargando…

AB010. Clinical significance of serum Cyfra 21-1 as a marker in thymic epithelial tumors

BACKGROUND: There have been no specific serum biomarkers for thymic epithelial tumors (TETs) yet. The study aimed to explore the diagnostic and prognostic value of potentially relevant serum tumor markers in TETs. METHODS: We retrospectively analyzed the database of our own with the aim of reviewing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Xiuxiu, Zhang, Xuefei, Fang, Wentao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792826/ http://dx.doi.org/10.21037/med-22-ab010

Ejemplares similares

AB006. Effectiveness of chemotherapy as the first-line treatment for thymic tumors with pleural dissemination
por: Zhang, Xuefei, et al.
Publicado: (2022)

AB005. Thymic carcinoma arising in a multilocular thymic cyst that previously went through complete remission after antibiotics treatment
por: Yu, Fenghao, et al.
Publicado: (2022)

Elevated serum CYFRA 21‐1 level as a diagnostic marker for thymic carcinoma
por: Shiiya, Haruhiko, et al.
Publicado: (2021)

Is total thymectomy always necessary for early-stage thymic epithelial tumors?- extended abstract
por: Yu, Fenghao, et al.
Publicado: (2022)

Clinical significance of serum CYFRA 21-1 in gastric cancer.
por: Nakata, B., et al.
Publicado: (1996)

AB002. Anlotinib as salvage treatment for patients with relapsed and refractory thymic epithelial tumors
por: Wang, Chang-Lu, et al.
Publicado: (2022)

AB012. Automated histologic subtyping of thymic epithelial tumors with deep learning
por: Dolezal, James M., et al.
Publicado: (2022)

AB008. Activated pathways of Thymic Epithelial Tumors: a RYTHMIC study
por: Benitez, Jose Carlos, et al.
Publicado: (2022)

AB010. Keloidal scleroderma with isolated intertriginous involvement
por: Balakrishnan, Vijay, et al.
Publicado: (2021)

Evaluation of serum cyfra21 in patients with pleural effusion
por: Azimi, Q, et al.
Publicado: (2012)

AB007. Expression of trophoblastic antigen 2 (Trop2) in thymic epithelial tumors
por: Yeung, Vincent, et al.
Publicado: (2022)

Diagnostic and Prognostic Significance of Serum Biomarkers – Serum Amyloid A and CYFRA 21-1 in Lung Cancer
por: Dhanurdhar, Yera, et al.
Publicado: (2023)

Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum
por: Weber, Daniel Gilbert, et al.
Publicado: (2010)

AB004. Radiotherapy for thymic epithelial tumors: what is the optimal dose?—a systematic review
por: Angrisani, Antonio, et al.
Publicado: (2022)

AB003. Benefits of proton radiotherapy in thymic epithelial tumors using the model-based approach
por: Peeters, Stephanie T. H., et al.
Publicado: (2022)

CYFRA 21-1 in urine: a diagnostic marker for endometriosis?
por: Gjavotchanoff, Risto
Publicado: (2015)

Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer
por: Uenishi, T, et al.
Publicado: (2003)

Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma
por: Hsu, Yin-Ping, et al.
Publicado: (2015)

Serum Levels of Cyfra 21 in Patients with Benign and Malignant Salivary Gland Tumors
por: Jeiroodi, Naghmeh, et al.
Publicado: (2017)

The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma
por: Li, Huiyang, et al.
Publicado: (2023)

Prognostic significance of pre-treatment serum Cyfra21-1 as a tumor marker in patients with oropharyngeal squamous cell carcinoma treated with concurrent chemoradiotherapy
por: Li, Liang, et al.
Publicado: (2020)

CYFRA 21-1 and Placental Growth Factor as Screening Markers for Endometriosis
por: Cho, Hye-yon, et al.
Publicado: (2019)

Evaluation of CYFRA 21.1 as a Dedifferentiation Marker of Advanced Thyroid Cancer
por: Malapure, Sumeet Suresh, et al.
Publicado: (2020)

AB010. Metabolic disturbance for prostate cancer therapy
por: Li, Benyi
Publicado: (2018)

CYFRA 21-1 serum levels in women with adnexal masses and inflammatory diseases.
por: Tempfer, C., et al.
Publicado: (1998)

Increases in Serum CYFRA21-1 Concentration during Successful Treatment with Crizotinib
por: Kanaji, Nobuhiro, et al.
Publicado: (2014)

Role of Serum CYFRA 21-1 in Diagnosis and Prognostic in Colorectal Liver Metastases
por: Li, Shirong, et al.
Publicado: (2023)

Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis
por: Zhang, Zhen, et al.
Publicado: (2017)

Prognostic value of serum CYFRA21-1 and CEA for non-small-cell lung cancer
por: Zhang, Zhi-Hui, et al.
Publicado: (2015)

Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma
por: Caviglia, Gian Paolo, et al.
Publicado: (2020)

Serum CYFRA 21-1 but not Vimentin is Associated with Poor Prognosis in Advanced Lung Cancer Patients
por: Kanaji, Nobuhiro, et al.
Publicado: (2019)

Serum CYFRA 21.1 Level Predicts Disease Course in Thyroid Cancer with Distant Metastasis
por: Jeong, Chaiho, et al.
Publicado: (2021)

Estimation of salivary and serum CYFRA 21-1 levels in patients with oral squamous cell carcinoma
por: Adusumilli, Praveena, et al.
Publicado: (2023)

AB010. Molecular pathophysiology of priapism: emerging targets and novel therapies
por: Burnett, Arthur L., et al.
Publicado: (2015)

On Target: CYFRA 21-1 as an Idiopathic Pulmonary Fibrosis Biomarker
por: Spagnolo, Paolo, et al.
Publicado: (2022)

Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.
por: Takada, M., et al.
Publicado: (1995)

Prognostic impact of serum CYFRA 21–1 in patients with advanced lung adenocarcinoma: a retrospective study
por: Ono, Akira, et al.
Publicado: (2013)

A Comparison of Serum CYFRA 21-1 and SCC Ag in the Diagnosis of Squamous Cell Lung Carcinoma
por: Kim, Young-Chul, et al.
Publicado: (1996)

Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis
por: Boher, J-M, et al.
Publicado: (1999)

Evaluation of the value of preoperative CYFRA21-1 in the diagnosis and prognosis of epithelial ovarian cancer in conjunction with CA125
por: Jin, Chunjing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bba2uk7cou3idlca6vkiteorii